Literature DB >> 3133110

Antitumor effect of intrapleural administration of Lactobacillus casei in mice.

T Matsuzaki1, T Yokokura, M Mutai.   

Abstract

The antitumor effect of intrapleural (i.pl.) administration of Lactobacillus casei YIT 9018 (LC 9018) on Meth A sarcoma in BALB/c mice was examined. Inoculation of Meth A cells into the thoracic cavity of BALB/c mice caused growth of the cells and the mice died from the tumor with an increased amount of pleural fluid. LC 9018 was given i.pl. to BALB/c mice before or after i.pl. inoculation of Meth A cells and the survival of the mice was determined. The i.pl. administration of LC 9018 was effective in prolonging the survival of the mice after i.pl. inoculation of Meth A tumor, and pretreatment with LC 9018 i.pl. also prolonged survival. Moreover, i.pl. administration of LC 9018 not only increased the number of thoracic exudate cells (TEC) but also augmented both cytolytic activity of thoracic macrophages and natural killer cell activity of TEC. Furthermore, phagocytic activity of thoracic macrophages against sheep red blood cells was enhanced and Ia antigen-positive cells in TEC were increased by the i.pl. treatment with LC 9018. These results showed that TEC induced by i.pl. administration of LC 9018 had antitumor activity against Meth A tumor inoculated i.pl. into BALB/c mice.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3133110     DOI: 10.1007/bf00199931

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  23 in total

1.  Biologically active components from mycobacterial cell walls. II. Suppression and regression of strain-2 guinea pig hepatoma.

Authors:  T J Meyer; E E Ribi; I Azuma; B Zbar
Journal:  J Natl Cancer Inst       Date:  1974-01       Impact factor: 13.506

2.  Immunotherapy of human malignant melanoma with oil-attached BCG cell-wall skeleton.

Authors:  Y Yamamura; K Yoshizaki; I Azuma; T Yagura; T Watanabe
Journal:  Gan       Date:  1975-08

3.  Adjuvant and antitumor activities of Nocardia cell-wall skeletons.

Authors:  I Azuma; T Taniyama; M Yamawaki; K Sugimura; Y Yamamura
Journal:  Gan       Date:  1976-10

4.  Association of macrophage activation with antitumor effect on rat syngeneic fibrosarcoma by Nocardia rubra cell wall skeleton.

Authors:  T Ogura; N Namba; F Hirao; Y Yamamura; I Azuma
Journal:  Cancer Res       Date:  1979-11       Impact factor: 12.701

5.  Effect of anticancer therapy of lymphocyte cytotoxicity in lung cancer patients.

Authors:  H Manabe; K Yasumoto; M Ohta; K Toyohira; K Nomoto
Journal:  Gan       Date:  1977-08

6.  Successful treatment of the patients with malignant pleural effusion with BCG cell-wall skeleton.

Authors:  Y Yamamura; T Ogura; T Yoshimoto; H Nishikawa; M Sakatani
Journal:  Gan       Date:  1976-10

7.  Intrapleural administration of OK432 in cancer patients: augmentation of autologous tumor killing activity of tumor-associated large granular lymphocytes.

Authors:  A Uchida; M Micksche; T Hoshino
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

Review 8.  Clinical immunotherapy trials of bacterial components derived from Mycobacteria and Nocardia.

Authors:  G J Vosika
Journal:  J Biol Response Mod       Date:  1983

9.  Intrapleural administration of OK432 in cancer patients: activation of NK cells and reduction of suppressor cells.

Authors:  A Uchida; M Micksche
Journal:  Int J Cancer       Date:  1983-01-15       Impact factor: 7.396

10.  Augmentation of host resistance to Listeria monocytogenes infection by Lactobacillus casei.

Authors:  K Nomoto; S Miake; S Hashimoto; T Yokokura; M Mutai; Y Yoshikai; K Nomoto
Journal:  J Clin Lab Immunol       Date:  1985-06
View more
  9 in total

1.  Antimicrobial activity of intraurethrally administered probiotic Lactobacillus casei in a murine model of Escherichia coli urinary tract infection.

Authors:  T Asahara; K Nomoto; M Watanuki; T Yokokura
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  Effect of intranasal administration of Lactobacillus casei Shirota on influenza virus infection of upper respiratory tract in mice.

Authors:  T Hori; J Kiyoshima; K Shida; H Yasui
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

3.  Dietary Emulsifier-Induced Low-Grade Inflammation Promotes Colon Carcinogenesis.

Authors:  Emilie Viennois; Didier Merlin; Andrew T Gewirtz; Benoit Chassaing
Journal:  Cancer Res       Date:  2016-11-07       Impact factor: 12.701

4.  Shuttle plasmid vectors for Lactobacillus casei and Escherichia coli with a minus origin.

Authors:  M Shimizu-Kadota; H Shibahara-Sone; H Ishiwa
Journal:  Appl Environ Microbiol       Date:  1991-11       Impact factor: 4.792

Review 5.  Emerging roles of lactic acid bacteria in protection against colorectal cancer.

Authors:  Li Zhong; Xufei Zhang; Mihai Covasa
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

Review 6.  Discovering probiotic microorganisms: in vitro, in vivo, genetic and omics approaches.

Authors:  Konstantinos Papadimitriou; Georgia Zoumpopoulou; Benoit Foligné; Voula Alexandraki; Maria Kazou; Bruno Pot; Effie Tsakalidou
Journal:  Front Microbiol       Date:  2015-02-17       Impact factor: 5.640

Review 7.  Mechanisms and therapeutic effectiveness of lactobacilli.

Authors:  Alessandro Di Cerbo; Beniamino Palmieri; Maria Aponte; Julio Cesar Morales-Medina; Tommaso Iannitti
Journal:  J Clin Pathol       Date:  2015-11-17       Impact factor: 3.411

Review 8.  Potential role of probiotics on colorectal cancer prevention.

Authors:  Mario Uccello; Giulia Malaguarnera; Francesco Basile; Velia D'agata; Michele Malaguarnera; Gaetano Bertino; Marco Vacante; Filippo Drago; Antonio Biondi
Journal:  BMC Surg       Date:  2012-11-15       Impact factor: 2.102

9.  Effect of combined intrapleural administration of Lactobacillus casei (LC9018) and adriamycin on experimental malignant pleurisy in mice.

Authors:  A Tohgo; N G Tanaka; H Okada; Y Osada
Journal:  Jpn J Cancer Res       Date:  1989-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.